Purchase Order 75N93020P01187

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Takara Bio USA, Inc. for Smarter Sequencing Reagent Kits valued at $12,350 on July 16, 2020, with firm fixed-price terms and an ultimate completion date of August 15, 2020. Place of performance is Palo Alto, California. No set-aside designation applies to this order.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Takara Bio USA, Inc. for $81,440.15 on September 11, 2018, for a library prep system. Performance occurs in Mountain View, California. The firm fixed price order was not set-aside and has an ultimate completion date of October 11, 2018.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Takara Bio USA, Inc. for SmartScribe Reverse Transcriptase and SeqAmp DNA Polymerase on August 27, 2020, with a firm fixed price of $12,483.00 and completion deadline of September 26, 2020. Work is performed in Mountain View, California.</p>

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Takara Bio USA, Inc. to provide SEQUENCING KITS. The $5,747.50 contract has a completion date of September 28, 2017. Takara Bio USA, Inc. is a for-profit manufacturer of biomedical products and services, including next-generation sequencing and molecular biology tools, that frequently provides specialized products to...

This is a $35,231.70 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Takara Bio USA, Inc. for the delivery of SMARTSCRIBE Reverse Transcriptase and SEQAMP DNA Kits. The contract does not have a set-aside designation. Takara Bio USA, Inc. is a for-profit manufacturer of biomedical products and reagents, frequently serving as a prime contractor on NIH, Environmental Protection...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for $14,688.00 for an Illumina reagent kit, with an award date of August 12, 2020 and completion date of September 11, 2020. The order is firm fixed price with no set-aside. Place of performance is San Diego, California.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for $20,170.38 on November 19, 2020, for laboratory consumables and equipment supplies. The order covers Big Dye Terminator V3 kits, microamp clear adhesive seals, microamp 96-well reaction plates, HIDI formamide, microamp film and plates, and related reagents. Place of performance is Carlsbad, California. The ultimate completion date was December 3, 2020. The purchase order was...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation on November 16, 2020, for $36,079.40 to supply 10 units of a transfection kit (catalog #A14525). Performance is located in Grand Island, New York. The order is firm fixed price with an ultimate completion date of November 23, 2020.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Tecan Genomics, Inc. for $35,595.00 on February 9, 2021, for Universal Plus mRNA-SEQ Library Preparation Kits (quantity 5). Performance occurs at Tecan Genomics' facility in Redwood City, California. The order is firm fixed price with no small business set-aside. Ultimate completion is scheduled for February 16, 2021.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Tecan Genomics, Inc. for $17,307.00 on April 28, 2020, with completion by May 8, 2020. The order procures universal plus mRNA reagents for COVID-19 research on a firm fixed-price basis. Work is performed in Redwood City, California. No set-aside applies to this order.</p>